Literature DB >> 24846486

Australia's response to HIV among people who inject drugs.

Annie Madden, Alex Wodak.   

Abstract

Australia's prompt and effective response to HIV among people who inject drugs is recognized internationally. In the early 1980s, there was growing awareness of the evolving threat presented by HIV. Despite erroneous but commonly held assumptions that people who inject drugs generally disregard their health, injecting drug users contributed significantly to Australia's response to HIV. They formed peer-based organizations which advocated for: engaging affected communities in policy development and implementation; funding for peer education; and access to sterile injecting equipment. While government fear of appearing to condone injecting illicit drugs delayed the bi-partisan political support needed to implement programs to provide readily accessible sterile injecting equipment, needles and syringe programs were established relatively quickly. Strong evidence supports the effectiveness, safety, and cost-effectiveness of Australia's early, decisive, and pragmatic public health and human rights-based approach. Without a comprehensive package of harm reduction and peer-based responses, HIV epidemics can develop rapidly among and from people who inject drugs.

Entities:  

Mesh:

Year:  2014        PMID: 24846486     DOI: 10.1521/aeap.2014.26.3.234

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN: 0899-9546


  9 in total

1.  Drug Treatment as HIV Prevention Among Women and Girls Who Inject Drugs From a Global Perspective: Progress, Gaps, and Future Directions.

Authors:  Sandra A Springer; Sarah Larney; Zahra Alam-Mehrjerdi; Frederick L Altice; David Metzger; Steven Shoptaw
Journal:  J Acquir Immune Defic Syndr       Date:  2015-06-01       Impact factor: 3.731

2.  Harm Minimisation Drug Policy Implementation Qualities: Their Efficacy with Australian Needle and Syringe Program Providers and People Who Inject Drugs.

Authors:  Danielle Resiak; Elias Mpofu; Roderick Rothwell
Journal:  Healthcare (Basel)       Date:  2022-04-22

Review 3.  HIV and the criminalisation of drug use among people who inject drugs: a systematic review.

Authors:  Kora DeBeck; Tessa Cheng; Julio S Montaner; Chris Beyrer; Richard Elliott; Susan Sherman; Evan Wood; Stefan Baral
Journal:  Lancet HIV       Date:  2017-05-14       Impact factor: 12.767

4.  Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia.

Authors:  Annie Madden; Max Hopwood; Joanne Neale; Carla Treloar
Journal:  Harm Reduct J       Date:  2018-08-15

5.  Achieving meaningful participation of people who use drugs and their peer organizations in a strategic research partnership.

Authors:  Graham Brown; Sione Crawford; Gari-Emma Perry; Jude Byrne; James Dunne; Daniel Reeders; Angela Corry; Jane Dicka; Hunter Morgan; Sam Jones
Journal:  Harm Reduct J       Date:  2019-06-10

6.  Court as a health intervention to advance Canada's achievement of the sustainable development goals : a multi-pronged analysis of Vancouver's Downtown Community Court.

Authors:  Regiane A Garcia; Kristi Heather Kenyon; Claire E Brolan; Juliana Coughlin; Daniel D Guedes
Journal:  Global Health       Date:  2019-12-18       Impact factor: 4.185

7.  Health worker perceptions of the impact of COVID-19 on harm reduction services for people who inject drugs.

Authors:  Loren Brener; Robyn Horwitz; Jake Rance; Theresa Caruana; Joanne Bryant
Journal:  Health Soc Care Community       Date:  2022-03-16

8.  HIV among people who inject drugs in India: a systematic review.

Authors:  Lucy Ngaihbanglovi Pachuau; Caterina Tannous; Mansi Vijaybhai Dhami; Kingsley Emwinyore Agho
Journal:  BMC Public Health       Date:  2022-08-10       Impact factor: 4.135

9.  Prevention of HIV and Other Sexually Transmissible Infections in Expatriates and Traveler Networks: Qualitative Study of Peer Interaction in an Online Forum.

Authors:  Gemma Crawford; Bruce Maycock; Rochelle Tobin; Graham Brown; Roanna Lobo
Journal:  J Med Internet Res       Date:  2018-09-05       Impact factor: 5.428

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.